Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Stem Cells (Dayton, Ohio)|November 1, 1993
c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndromeC S Rosenfeld, J Nemunaitis, C R Sherer, et al.
American Journal of Clinical Oncology|August 26, 1998
Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancerJ Nemunaitis, C D Buckner, K S Dorsey, et al.
Blood|March 1, 1993
Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpuraZ R Zeigler, C S Rosenfeld, J J Nemunaitis, et al.
Archives of Gynecology and Obstetrics|August 23, 2002
Spontaneous prolonged hypertonic uterine contractions (essential uterine hypertonus) and a possible infective etiologyG I Meniru, E Brister, J Nemunaitis-Keller, et al.
American Journal of Clinical Oncology|June 17, 1998
Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trialJ Nemunaitis, J Cox, W Meyer, et al.
American Journal of Clinical Oncology|December 22, 1999
A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxelA N Gordon, K C Hancock, C M Matthews, et al.
British Journal of Cancer|July 11, 2002
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancerS R Bramhall, J Schulz, J Nemunaitis, et al.
Seminars in Radiation Oncology|October 21, 2000
Gene replacement strategies for treating non-small cell lung cancerJ A Roth, S F Grammer, S G Swisher, et al.
Bone Marrow Transplantation|March 1, 1993
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantationR Pene, F R Appelbaum, L Fisher, et al.
Frontiers in Oncology|May 10, 2021
Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell CarcinomaRobert E Sobol, Kerstin B Menander, Sunil Chada, et al.
Pageof 17